VK
Vijay Kumar
About Vijay Kumar
Data last updated:
Vijay Kumar is a Director at Abryl Laboratories Private Limited (since 2016). The companies operate in Pharma and Healthcare. Abryl Laboratories Private Limited reported revenue of ₹36.91 Cr (FY 2025). Earlier, Vijay Kumar was an Additional Director at Sb Edifice Private Limited (2014–2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Jan 2016 | 2016 | ₹36.91 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 17 Oct 2014 | 2012 | ₹109 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vijay Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arshpreet Kaur Guliani | Abryl Laboratories Private Limited | Company Secretary | |
| Jayant Singla | 06995928 | Abryl Laboratories Private Limited | Director |
| Sakshi Maheshwari | Abryl Laboratories Private Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vijay Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vijay Kumar
Vijay Kumar currently holds 1 directorship: Abryl Laboratories Private Limited (Director, since 20 Jan 2016, revenue ₹36.91 Cr (FY 2025)).
Vijay Kumar was first appointed on 17 Oct 2014 as Additional Director at Sb Edifice Private Limited. The most recent appointment on record is 20 Jan 2016 at Abryl Laboratories Private Limited.
Vijay Kumar held 1 earlier board appointment: Sb Edifice Private Limited (Additional Director, 17 Oct 2014 to 07 Mar 2017).
The current boards of Vijay Kumar's companies include Arshpreet Kaur Guliani (Abryl Laboratories Private Limited), Jayant Singla (Abryl Laboratories Private Limited), Sakshi Maheshwari (Abryl Laboratories Private Limited).